98 related articles for article (PubMed ID: 29913480)
1. Dendrimer-paclitaxel complexes for efficient treatment in ovarian cancer: study on OVCAR-3 and HEK293T cells.
Yao H; Ma J
Acta Biochim Pol; 2018; 65(2):219-225. PubMed ID: 29913480
[TBL] [Abstract][Full Text] [Related]
2. Biotinylated poly(amido)amine (PAMAM) dendrimers as carriers for drug delivery to ovarian cancer cells in vitro.
Yellepeddi VK; Kumar A; Palakurthi S
Anticancer Res; 2009 Aug; 29(8):2933-43. PubMed ID: 19661298
[TBL] [Abstract][Full Text] [Related]
3. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
4. Octa-arginine modified poly(amidoamine) dendrimers for improved delivery and cytotoxic effect of paclitaxel in cancer.
Rompicharla SVK; Kumari P; Ghosh B; Biswas S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):847-859. PubMed ID: 29790795
[TBL] [Abstract][Full Text] [Related]
5. Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines.
Uram Ł; Filipowicz A; Misiorek M; Pieńkowska N; Markowicz J; Wałajtys-Rode E; Wołowiec S
Eur J Pharm Sci; 2018 Nov; 124():1-9. PubMed ID: 30118847
[TBL] [Abstract][Full Text] [Related]
6. Multicomponent Conjugates of Anticancer Drugs and Monoclonal Antibody with PAMAM Dendrimers to Increase Efficacy of HER-2 Positive Breast Cancer Therapy.
Marcinkowska M; Stanczyk M; Janaszewska A; Sobierajska E; Chworos A; Klajnert-Maculewicz B
Pharm Res; 2019 Sep; 36(11):154. PubMed ID: 31482205
[TBL] [Abstract][Full Text] [Related]
7. Lipid-dendrimer hybrid nanosystem as a novel delivery system for paclitaxel to treat ovarian cancer.
Liu Y; Ng Y; Toh MR; Chiu GNC
J Control Release; 2015 Dec; 220(Pt A):438-446. PubMed ID: 26551345
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin.
Kirkpatrick GJ; Plumb JA; Sutcliffe OB; Flint DJ; Wheate NJ
J Inorg Biochem; 2011 Sep; 105(9):1115-22. PubMed ID: 21704583
[TBL] [Abstract][Full Text] [Related]
10. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
12. Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier.
Hemmer R; Hall A; Spaulding R; Rossow B; Hester M; Caroway M; Haskamp A; Wall S; Bullen HA; Morris C; Haik KL
Molecules; 2013 Sep; 18(9):11537-52. PubMed ID: 24048286
[TBL] [Abstract][Full Text] [Related]
13. Functionalized nanospheres for targeted delivery of paclitaxel.
Bushman J; Vaughan A; Sheihet L; Zhang Z; Costache M; Kohn J
J Control Release; 2013 Nov; 171(3):315-21. PubMed ID: 23792807
[TBL] [Abstract][Full Text] [Related]
14. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
[TBL] [Abstract][Full Text] [Related]
15. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
16. Grafting, characterization and enhancement of therapeutic activity of berberine loaded PEGylated PAMAM dendrimer for cancerous cell.
Yadav D; Semwal BC; Dewangan HK
J Biomater Sci Polym Ed; 2023 Jun; 34(8):1053-1066. PubMed ID: 36469754
[TBL] [Abstract][Full Text] [Related]
17. Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier.
Teow HM; Zhou Z; Najlah M; Yusof SR; Abbott NJ; D'Emanuele A
Int J Pharm; 2013 Jan; 441(1-2):701-11. PubMed ID: 23089576
[TBL] [Abstract][Full Text] [Related]
18. Dendrimer versus linear conjugate: Influence of polymeric architecture on the delivery and anticancer effect of paclitaxel.
Khandare JJ; Jayant S; Singh A; Chandna P; Wang Y; Vorsa N; Minko T
Bioconjug Chem; 2006; 17(6):1464-72. PubMed ID: 17105225
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of targeting ligands surface modified paclitaxel nanocrystals.
Sohn JS; Yoon DS; Sohn JY; Park JS; Choi JS
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():228-237. PubMed ID: 28024581
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of interactions between a PAMAM dendrimer-paclitaxel conjugate and a biomembrane.
He X; Lin M; Lu T; Qu Z; Xu F
Phys Chem Chem Phys; 2015 Nov; 17(44):29507-17. PubMed ID: 26256278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
